Catalyst Trusteeship pledges additional 3.4 million MedPlus shares
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.3 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Catalyst Trusteeship Ltd, acting as debenture trustee for debenture holders, created pledges over 3,400,000 MedPlus shares on September 29 and October 23, 2026. This equals 2.83% of share capital. Encumbered holdings rose from 20,750,400 shares, or 17.27%, to 24,150,400 shares, or 20.10%. No shares were bought or sold and voting ownership did not change.
Voting ownership is unchanged. The pledge adds collateral for debenture holders and may weigh on sentiment if the pledged shares are later sold.